Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger protein 216 pseudogene 1 (RNF216P1) is a non-coding genomic sequence in humans, annotated as a pseudogene with sequence similarity to the functional gene encoding ring finger protein 216. Pseudogenes like RNF216P1 typically do not encode functional proteins and are not considered viable molecular targets for therapeutics. There is no confirmed biological function, disease association, or druggability. This gene is cataloged in databases such as GeneCards, NCBI Gene, and Ensembl as a pseudogene, and is identified by alternative symbols such as RNF216L and hCG2040556.
None; no drug interaction or mechanism identified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein 216 pseudogene 1 (RNF216P1).